Search Results

Intra-Arterial Therapy for Glioblastoma: Beyond Access to Effective Tumor Delivery

A neurointerventional perspective on technique, limitations, and the evolving role of precision delivery strategies.

By Juan Diego Alzate, MD, MSc; John Boockvar, MD; David Langer, MD; Miroslaw Janowski, MD, PhD; and Yafell Serulle, MD, PhD

New Directions in Neurointervention

By Pascal Jabbour, MD

Applying Existing Technologies to Vascular Applications

Examples of how current technologies in wearables, tissue engineering, and imaging and computer simulation could be applied to vascular care in the future.

By David H. Deaton, MD, FACS

The Promise of MR for TEVAR and EVAR

Obtaining both force and anatomic imaging and how this might affect endovascular repair.

By Felix J.V. Schlösser, MD; Hamid R. Mojibian, MD; Hence J.M. Verhagen, MD, PhD; Frans L. Moll, MD, PhD; David Gortler, PharmD; and Bart E. Muhs, MD, PhD

An Interview With David H. Deaton, MD

A prominent vascular surgeon shares his experiences with AAA devices, the PAD Coalition, and how surgery is a family business.

Liver Mass

Panelists: Raj Narayanan, MD; David Lu, MD; and Fred T. Lee Jr, MD

Yttrium-90 Radioembolization

Recent advances in hepatic embolotherapy.

By David M. Liu, MD, FRCP(C); David N. Cade, MD; Jesse Knight, MD; Rodney Raabe, MD; Stephen Kee, MD; Andrew Kennedy, MD, FACRO; and Riad Salem, MD, FSIR, MBA

The Next Generation of Aortic Endografts

Developing trends and new technologies.

By David H. Deaton, MD

Practical Lessons From PRESERVE

Highlights of the study’s methods and results, with insights from the study's Principal Investigators, David L. Gillespie, MD, FACS, and Matthew S. Johnson, MD, FSIR.

Colorectal Hepatic Metastasis

The past, present, and future role of liver-directed therapy.

By David M. Liu, MD, FRCP(C), FSIR; Ripal Gandhi, MD, FSVM; and Alda Lui Tam, MD, MBA

Regulation of Peripheral Vascular Devices

Current issues in the regulation of SFA stents.

By David S. Buckles; Jennifer L. Goode; and Dorothy B. Abel

Emerging Trends in Interventional Oncology

By Ripal T. Gandhi, MD, FSIR, FSVM, and David M. Liu, MD, FRCPC, FSIR

Particulate Embolics

The background, available options, and ideal applications of particulate embolics.

By Marcelo Guimaraes, MD; David Arrington, MD; Timothy MacFall, MD; Ricardo Yamada, MD; and Claudio Schönholz, MD

Surgery or Stenting?

Most experienced clinicians continue to consider CEA the standard of care.

By DAVID H. DEATON, MD, FACS

Down and Dirty With Dosimetry

A practical understanding and approach to radioembolization.

By David M. Liu, MD, FRCPC, FSIR; Mark Westcott, MD; Ricardo Garcia-Monaco, MD, PhD, FSIR; Robert Abraham, MD, FRCPC, FSIR; and Ripal Gandhi, MD, FSVM